Gene editing holds promise for babies with deadly immune disease.
Nature, 616(7955): 11 PMID 36964239 DOI 10.1038/d41586-023-00870-z
Abstract
This article has no abstract in PubMed.
Your browser does not allow saving data (e.g. private mode): bookmarks will be lost when the tab closes.